Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's drug
Pharma
FDA shoots down Amneal's Parkinson's med
Amneal's hopes for a midyear launch of its extended-release Parkinson's disease prospect have been put on ice.
Fraiser Kansteiner
Jul 5, 2023 11:08am
Neurocrine gives up on Parkinson's drug Ongentys
May 3, 2023 10:55am
Targeting $500M market, Amneal files for Parkinson's approval
Sep 2, 2022 7:55am